Retatrutide Pen Guide: Specs, Storage & Administration
The 30mg retatrutide pen: 300 clicks, 0.1mg per click, 60-click max dial, refrigerated 2–8°C storage, and a 28-day in-use window. This page owns the device — specs, priming, administration, and needle fit. For exact mg-to-click lookup use the pen clicks guide; for pen-count and duration math use the calculator; for the TRIUMPH titration schedule see the dosage guide.
Update History ▾
April 14, 2026: Removed click-table overlap, stripped commercial routing, and tightened the page around hardware, storage, priming, and needle fit
April 13, 2026: Tightened device-first positioning, clarified calculator versus clicks-chart routing, and refreshed the storage/priming promise
April 8, 2026: Repositioned the page around pen mechanics, storage, and handling rather than general dose-planning
March 14, 2026: Initial publication
The 30mg retatrutide pen is a prefilled multi-dose device: 30mg total content, 300 clicks, 0.1mg per click, and a 60-click / 6mg maximum dial per single administration. This page covers the device — specifications, storage, priming, administration, and needle fit. For exact dose conversions, use the pen clicks chart. For pen-duration and pen-count math, use the calculator. For the TRIUMPH titration schedule, use the dosage guide. For research-use availability in the UAE, see the Retatrutide UAE supply page.
- 30mg total retatrutide per pen
- 300 clicks per pen
- 0.1mg per click
- 60-click / 6mg max single dial
- 28-day in-use window
- 30G or 31G needle, 4–8mm
Understanding the Retatrutide Pen: How It Works
A retatrutide pen is a prefilled, multi-dose subcutaneous injection device holding retatrutide in a ready-to-use liquid formulation.[6] Unlike a lyophilised vial that must be reconstituted with bacteriostatic water before each use, the pen ships pre-loaded and uses a click-based dial mechanism for precise dose selection. Each click of the dial dispenses exactly 0.1mg of retatrutide — mechanical, repeatable, and independent of syringe markings.
In this content cluster, the pen guide owns the hardware question: 30mg total content, 300 clicks, 0.1mg per click, storage rules, priming, administration, and compatible needles. The approval page owns FDA status; the dosage guide owns the TRIUMPH titration schedule; and the clicks guide owns the exact mg-to-click lookup table.
The pen format is well suited to research protocols that demand repeated, precisely metered doses across multi-week titration schedules. The dial supports stepwise escalation and individualised adjustments mirroring the protocols used across published Phase 2 and Phase 3 retatrutide trials.[1] If you need the weekly titration schedule, use the dosage guide. For direct mg-to-click conversion, use the clicks chart. For pen-count and protocol-length planning, use the calculator.
What Are the Pen Specifications?
The retatrutide 30mg pen is a prefilled multi-dose device. The nine spec rows below cover everything you need before reaching for the pen clicks guide or calculator.
| Specification | Detail |
|---|---|
| Format | Prefilled Pen |
| Total Content | 30mg retatrutide |
| Total Clicks | 300 clicks |
| Dose per Click | 0.1mg |
| Maximum Single Dose | 60 clicks (6mg) |
| Administration | Subcutaneous injection |
| Needle Compatibility | Standard pen needles (30G/31G, 4–8mm) |
| Storage (unopened) | 2–8°C (refrigerated) |
| Storage (in use) | Room temp (≤25°C) or refrigerated, 28-day window |
The 60-click cap per single administration is a mechanical limit of the dial — the dose dial physically stops at 60. Doses above 6mg in a single research session require splitting across two injections; for the exact split-dose lookup table, use the retatrutide pen clicks guide. The TRIUMPH Phase 3 program titrates retatrutide stepwise up to a 12mg weekly target dose, and the full escalation schedule lives in the dosage guide.[3]
How Do You Use a Retatrutide Pen?
Six steps cover the full administration cycle. End-to-end the process takes around five minutes once the pen has equilibrated to room temperature.
Step 1 — Prepare
Take the pen out of the refrigerator 15–30 minutes before use so it reaches room temperature; cold subcutaneous injections sting more. Inspect the cartridge through the viewing window: the solution must be clear and colourless with no particles or cloudiness. Discard the pen if the contents are discoloured, particulate, or have been frozen.
Step 2 — Attach Needle
Peel the paper seal from a fresh single-use pen needle. Screw or push the needle straight onto the pen tip until it is secure. Remove the outer cap (set it aside for disposal) and the inner cap (discard). Always use a new needle for every administration — reused needles dull, contaminate, and risk leakage.
Step 3 — Prime
Priming clears air from the cartridge and confirms the dial-to-needle path is open. Dial 2 clicks (0.2mg). Hold the pen with the needle pointing up, tap the cartridge to move any bubbles to the top, then press the plunger fully until a drop appears at the needle tip. If no drop appears, repeat. Prime before each new needle attachment.
Step 4 — Select Dose
Turn the dial to the required number of clicks — each click equals 0.1mg. The dial moves bidirectionally, so an overdial corrects back without wasting solution. The mechanical cap is 60 clicks (6mg) per administration. For direct mg-to-click lookup use the pen clicks guide; for pen-duration math use the calculator; for the TRIUMPH titration schedule use the dosage guide.
Step 5 — Administer
Clean the injection site with an alcohol swab. Pinch the skin if using a needle longer than 5mm. Insert the needle at 90° into the subcutaneous tissue of the abdomen, thigh, or upper arm. Press the plunger fully and hold for 10 seconds before withdrawal so the full dose clears the cartridge.[6] The 10-second hold is what prevents leakage at the injection site.
Step 6 — Remove & Store
Withdraw the needle, twist or pull it off the pen, and drop it straight into a sharps container. Replace the pen cap and return the pen to storage at room temperature (≤25°C) or in the refrigerator at 2–8°C. For injection-site reactions and tolerability notes, see the retatrutide side effects guide.
When Should You Use the Clicks Guide or Calculator?
This page is the device reference. Three sibling pages handle the rest:
- Mg-to-click lookup: use the retatrutide pen clicks guide for the exact conversion table, including split-dose entries above the 60-click dial cap.
- Pen-count and protocol-length math: use the calculator to model how many pens a multi-week titration burns through.
- Weekly titration schedule: use the dosage guide for the stepwise TRIUMPH escalation pattern.[3]
The one device rule that belongs here, not in the calculator, is the 28-day in-use window: once the pen enters active use, storage timing constrains the protocol just as much as the volume left in the cartridge.
Pen vs Lyophilised Vial — Which Format?
Retatrutide is available in two delivery formats: prefilled pens (10mg entry pen, 20mg pen, 30mg flagship pen) and lyophilised powder vials (10mg vial, 40mg vial). The trade-offs cluster around accuracy, convenience, contamination risk, and cost per milligram.
| Factor | Prefilled Pen | Lyophilised Vial |
|---|---|---|
| Preparation | Ready to use — no mixing | Requires reconstitution with bacteriostatic water |
| Dosing Accuracy | 0.1mg per click — mechanical precision | Depends on syringe volume markings |
| Contamination Risk | Low — sealed cartridge, no open transfer | Higher — multi-step reconstitution introduces contamination vectors |
| Convenience | High — dial, inject, store | Low — requires vials, syringes, BAC water, mixing |
| Portability | Compact, self-contained | Requires carrying separate supplies |
| Cost per mg | Higher upfront cost | Typically lower per mg |
| Shelf Life (unopened) | Refrigerated, manufacturer specified | Longer — lyophilised powder is more stable |
| In-Use Window | 28 days after first use | 28 days after reconstitution |
| Skill Required | Minimal — no reconstitution knowledge needed | Moderate — must understand reconstitution ratios |
For most research protocols, the pen format offers the best balance of accuracy, convenience, and contamination control. The vial format may be preferred when cost per milligram is the primary consideration or when researchers need to prepare custom concentrations. For a broader comparison of retatrutide against other compounds, see our retatrutide vs tirzepatide comparison.
How Should a Retatrutide Pen Be Stored?
Proper storage is critical for maintaining peptide integrity and ensuring consistent research results. Retatrutide is a peptide that degrades when exposed to heat, light, or repeated freeze-thaw cycles.
Before First Use
- Store at 2–8°C (standard refrigerator temperature)
- Do not freeze — freezing can damage the peptide structure and the pen mechanism
- Keep in original packaging to protect from light
- Store upright if possible
After First Use
- Can be stored at room temperature (up to 25°C) or returned to the refrigerator
- 28-day use window — discard the pen 28 days after the first dose, regardless of remaining content
- Do not expose to temperatures above 30°C
- Avoid direct sunlight or prolonged UV exposure
- Always remove the needle after each use to prevent contamination and leakage
For underlying peptide degradation kinetics, see the peptide stability and storage guide. In hot climates such as the UAE — where ambient temperatures regularly exceed 45°C — temperature-controlled transport and refrigerated storage are non-negotiable. The Retatrutide UAE supply page covers the cold-chain logistics we use for Dubai-based research orders.
What Needles Are Compatible?
The Remy Peptides retatrutide pen uses standard pen needles that are universally compatible with most prefilled pen injectors. Pen needles are sold separately and should be single-use only.
| Needle Spec | Recommended | Notes |
|---|---|---|
| Gauge | 30G or 31G | Thinner gauge = less discomfort |
| Length | 4mm or 5mm | Suitable for subcutaneous delivery in most body compositions |
| Alternative Length | 6mm or 8mm | May be needed for larger body compositions |
| Brands | BD Micro-Fine, NovoFine, Owen Mumford | Any standard pen needle with universal screw-on fitting |
Key needle rules: Always use a new needle for each administration. Never leave a needle attached to the pen between uses—this can cause air entry, contamination, and medication leakage. Dispose of used needles in a proper sharps container immediately after use.
Our Research Standards
This article cites peer-reviewed studies, FDA filings, and ClinicalTrials.gov data. All claims are cross-referenced against primary sources. We update articles when new trial data or regulatory decisions are published. Read our editorial policy →
Sources
- Jastreboff AM, et al. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. N Engl J Med. 2023;389(6):514–526. nejm.org
- Janoshik Analytical — Certificate of Analysis, Batch RETP002. HPLC purity: 99.262%. remypeptides.com/coa
- Eli Lilly. TRIUMPH Clinical Trial Program for Retatrutide. clinicaltrials.gov ↩
- Rosenstock J, et al. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-comparator-controlled, parallel-group, phase 2 trial. Lancet. 2023;402(10401):529–544.
- Frias JP, et al. Efficacy and safety of LY-3437943, a novel triple GIP/GLP-1/glucagon receptor agonist in patients with type 2 diabetes. Lancet. 2022;400(10366):1869–1881.
- USP General Chapter <1>. Injections and Implanted Drug Products. United States Pharmacopeia. ↩